# Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors

> **NCT02276053** · — · COMPLETED · sponsor: **UCB BIOSCIENCES GmbH** · enrollment: 93 (actual)

## Conditions studied

- Brain Tumor Related Epilepsy (BTRE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02276053
- **Lead sponsor:** UCB BIOSCIENCES GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-27
- **Primary completion:** 2017-12-04
- **Final completion:** 2017-12-04
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2020-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276053, "Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02276053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*